Wednesday, December 17, 2014 9:28:49 AM
Efficacy studies, if needed, are not a surprise. The FDA has been burned by every ART/ADT product thus far and are just protecting themselves downstream if is something happens. That said, nobody knows if the FDA has even gotten back to Elite since the 11/18 meeting. What we do know is that Elite is ready to file and they will not do so until they hear back from the FDA that they meet the filing requirements. This is a very smart approach to filing and we can thank Carmargo -- who has prior FDA reviewers and staffers on its' own staff -- for such guidance. The filing could happen at anytime. If Elite is required to do an efficacy study, the study design and plan has been prepared by Elite, Carargo and CFI Lifetree. This study should take three months at most and does not impact the actual timeline for final approval. In addition, Elite has been told they will receive designated expedited review from the FDA. Things will move very fast. Most importantly, all the prior BE data data tells us the efficacy studies will be successful. These are very well known, clinically acceptable analgesics, pain relievers and an opiate antagonist that have been used for decades. The FDA knows this, because they have approved each one. Lastly, the positive HAL studies will tell us why the this delivery system will be embraced by the clinical community and penetrate this market rapidly.
In regards to Elite's generics. The majority of those will never be produced and it has been and still is posturing. A couple decent money makers are certainly lined up (Isradapine and TBD) to ensure cash was coming in while they worked on their first submission, but I believe after Elite secured the financing they needed, the majority of generics were truly put on the back burner. People harping on these generics are missing the bigger picture of why Hakim was brought on board at Elite. For those that cannot connect the dots, I will simplify it, for the full story is complicated, years in the making and spiderwebs to many places. But to put it simply, he is here to launch a full line of abuse deterrent painkillers. The first of those will be filed soon and approved and the set the stage for a little unknown company to jolt the pharma industry.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM